CTOs on the Move

Hamlin Tool and Machine Co

www.hamlintool.com

 
Hamlin Tool and Machine Co is a Rochester Hls, MI-based company in the Manufacturing sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Wesley Homes

Wesley Homes is a mission driven not-for-profit organization that provides a network of services offering a continuum of care for older adults. It is affiliated with the Pacific Northwest Conference of the United Methodist Church . Well known for its

Lake Bass Cheese Factory Inc

Lake Bass Cheese Factory Inc is a Somerset, WI-based company in the Manufacturing sector.

Matthews International Corporation, Bronze Division

Matthews International Corporation, Bronze Division is a Pittsburgh, PA-based company in the Manufacturing sector.

Nagatoshi Produce

Nagatoshi Produce is a Los Angeles, CA-based company in the Manufacturing sector.

enVVeno

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.